Balasubramaniam Shamila, Lim Shueh Lin, Goh Lay Hoon, Subramaniam Sivasangari, Tangiisuran Balamurugan
School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, USM, Pulau Pinang, Malaysia.
Endocrinology Unit, Hospital Pulau Pinang, Jalan Residensi, 10990, Georgetown, Pulau Pinang, Malaysia.
Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2585-2591. doi: 10.1016/j.dsx.2019.07.011. Epub 2019 Jul 9.
Illness perceptions (IP) involve coping strategies and behavioural responses that can influence glycaemic control. Despite the importance of good glycaemic control, the majority of patients in Asia are not achieving glycaemic targets. An evaluation of IP in association with glycaemic control, medication adherence and chronic kidney disease (CKD) in Type 2 diabetes mellitus patients (T2DM) was carried out in an outpatient setting in Malaysia METHOD: A cross-sectional study was conducted using the Revised Illness Perception Questionnaire in a purposive sample of 384 T2DM patients.
There were 55.7% females, median age was 58.2 years and median duration of diabetes was 13 years. The majority (79.4%) of patients had poor diabetes control (HbA1c ≥ 7.0%) and 39.6% of patients had low medication adherence. Patients with good glycaemic control had a higher Timeline Acute/Chronic and Emotional Representations score, hence they held the correct belief that diabetes is chronic and experienced negative emotions. Highly adherent patients had a higher Illness Coherence (χ2 = 21.385, p < 0.001) score but a lower Consequences (χ2 = 17.592, p < 0.001) and Emotional Representations (χ2 = 16.849, p < 0.001) score indicating good understanding and less negative perceptions of disease burden. Patients in a more advanced stage of CKD had a significantly higher Timeline Cyclical score (χ2 = 18.718, p = 0.001), believing that diabetes was unpredictable.
Dimensions of IP have been shown to be significantly associated with the assessed variables, therefore intervention studies with education, support and counselling should be conducted in Asia with the ultimate aim of empowering patients through IP-targeted management.
疾病认知(IP)涉及应对策略和行为反应,这些会影响血糖控制。尽管良好的血糖控制很重要,但亚洲大多数患者并未达到血糖目标。在马来西亚的一个门诊环境中,对2型糖尿病患者(T2DM)的疾病认知与血糖控制、药物依从性和慢性肾脏病(CKD)之间的关系进行了评估。
采用修订后的疾病认知问卷,对384例T2DM患者进行了一项横断面研究。
女性占55.7%,中位年龄为58.2岁,糖尿病中位病程为13年。大多数(79.4%)患者的糖尿病控制不佳(糖化血红蛋白≥7.0%),39.6%的患者药物依从性低。血糖控制良好的患者在时间轴急性/慢性和情感表征方面得分较高,因此他们正确地认为糖尿病是慢性疾病并经历负面情绪。高依从性患者的疾病连贯性得分较高(χ2 = 21.385,p < 0.001),但后果得分(χ2 = 17.592,p < 0.001)和情感表征得分(χ2 = 16.849,p < 0.001)较低,表明对疾病负担有良好的理解且负面认知较少。处于CKD更晚期阶段的患者时间轴周期性得分显著更高(χ2 = 18.718,p = 0.001),认为糖尿病不可预测。
已表明疾病认知的各个维度与所评估的变量显著相关,因此在亚洲应开展以教育、支持和咨询为内容的干预研究,最终目标是通过针对疾病认知的管理增强患者的能力。